 NEW YORK, Dec. 10, 2020 PRNewswire -- Hoth Therapeutics, Inc. NASDAQ: HOTH, a biopharmaceutical company, today announced that is has received Human Research Ethics Committee HREC clearance to commence the first cohort of the Phase 1b clinical trial of BioLexa Lotion for the... 